Now Playing
AI Capital Concentration: VC Bifurcation, Anduril $61B & IPO Bottleneck
Audio is available on Spreaker — see link below.
Half of all US venture capital value now sits in AI companies — and the three-point-six times valuation premium over non-AI peers is reshaping who gets funded and who doesn't. Today's briefing covers the quantified bifurcation, Anduril's $5B Series H, Fractile's inference hardware bet, and why the IPO backlog may not deliver the liquidity founders are waiting for.
Audio is available on Spreaker — see link below.
Half of all US venture capital value now sits in AI companies. That's not a projection.
The distortion at the top is extreme. OpenAI raised at an eight-hundred-fifty-two billion dollar valuation.
Away from pure AI, the other major capital story is Anduril. The defense tech company raised five billion dollars in a Series H led by Thrive Capital and Andreessen Horowitz, reaching a sixty-one billion dollar valuation.
One of the cleaner structural shifts in the data is the emergence of inference hardware as its own investment category. Fractile raised two-hundred-twenty million dollars in a Series B to build AI inference chips.
The IPO market isn't helping. Fifteen VC-backed IPOs in Q1 is not enough to clear the backlog.
Healthcare AI rounds are expanding quietly in the background. Forus raised one-hundred-sixty million for AI-powered medication access, and nine-am-Health closed twenty-six million for chronic care management.
Chapter summary auto-generated from the verified script. Listen to the full episode for the complete content.